NYSE:HYH - Halyard Health Stock Price, News, & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Sign in or create an account to add this stock to your watchlist.
Previous Close$57.25
Today's Range$56.93 - $57.91
52-Week Range$38.22 - $61.52
Volume886,271 shs
Average Volume438,537 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Halyard Health, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. Halyard Health, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Receive HYH News and Ratings via Email

Sign-up to receive the latest news and ratings for HYH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone678-425-9273

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Halyard Health (NYSE:HYH) Frequently Asked Questions

What is Halyard Health's stock symbol?

Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."

How were Halyard Health's earnings last quarter?

Halyard Health (NYSE:HYH) announced its quarterly earnings results on Wednesday, November, 1st. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.47 by $0.13. The medical instruments supplier had revenue of $401.40 million for the quarter, compared to the consensus estimate of $394.54 million. The company's quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.48 EPS. View Halyard Health's Earnings History.

What price target have analysts set for HYH?

2 brokerages have issued 12-month price objectives for Halyard Health's stock. Their predictions range from $58.00 to $67.00. On average, they expect Halyard Health's stock price to reach $62.50 in the next year. View Analyst Price Targets for Halyard Health.

What is the consensus analysts' recommendation for Halyard Health?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Halyard Health in the last year. There are currently 1 sell rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Halyard Health.

Has Halyard Health been receiving favorable news coverage?

News articles about HYH stock have been trending somewhat positive on Thursday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Halyard Health earned a news impact score of 0.7 on InfoTrie's scale. They also gave news articles about the medical instruments supplier a news buzz of 7.0 out of 10, meaning that recent news coverage is likely to have an effect on the stock's share price in the near term.

Who are some of Halyard Health's key competitors?

What other stocks do shareholders of Halyard Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Halyard Health investors own include Cisco Systems (CSCO), Allergan (AGN), Kimberly Clark (KMB), Celgene (CELG), Intel (INTC), General Electric (GE), Johnson & Johnson (JNJ), Kinder Morgan (KMI), Gilead Sciences (GILD) and Alphabet (GOOG).

Who are Halyard Health's key executives?

Halyard Health's management team includes the folowing people:
  • Mr. Steven E. Voskuil, Sr. VP & CFO (Age 50)
  • Mr. John W. Wesley, Sr. VP & Gen. Counsel (Age 59)
  • Ms. Rhonda D. Gibby, Sr. VP & Chief HR Officer (Age 50)
  • Mr. Joseph F. Woody, CEO & Director (Age 52)
  • Mr. Renato Negro, VP, Controller & Chief Accounting Officer

What is Halyard Health's official website?

The official website for Halyard Health is http://www.halyardhealth.com/.

How can I contact Halyard Health?

Halyard Health's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier can be reached via phone at 678-425-9273 or via email at [email protected]


MarketBeat Community Rating for Halyard Health (NYSE HYH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  238 (Vote Outperform)
Underperform Votes:  245 (Vote Underperform)
Total Votes:  483
MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe HYH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HYH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel